Dwight E Heron
Overview
Explore the profile of Dwight E Heron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
257
Citations
3078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jahraus C, Wallner P, Heron D, Crook W, Finkelstein S, Harris A, et al.
Cureus
. 2024 Nov;
16(11):e74098.
PMID: 39575357
Radiation oncology is among the most data-driven specialties in medicine. Recently, a wealth of peer-reviewed data has been published supporting the treatment of oligometastatic malignancies, demonstrating improved survival with metastasis-directed...
2.
3.
Coleman C, Wong R, Petereit D, Maguire P, Heron D, Steinberg M, et al.
J Natl Cancer Inst
. 2023 Sep;
115(12):1465-1474.
PMID: 37707545
The burden of cancer and access to effective treatment are not experienced equally by all in the United States. For underserved populations that often access the health-care system when their...
4.
Milano M, Soltys S, Marks L, Heron D, Yorke E, Grimm J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Nov;
115(2):294-296.
PMID: 36400622
No abstract available.
5.
Ferris R, Moskovitz J, Kunning S, Ruffin A, Reeder C, Ohr J, et al.
Clin Cancer Res
. 2022 Jan;
28(7):1335-1344.
PMID: 35091445
Purpose: Concurrent radiotherapy with cetuximab, an anti-EGFR mAb, is a standard treatment for locally advanced head and neck squamous carcinoma (HNSCC). Cytotoxic T lymphocyte antigen-4-positive (CTLA-4+) regulatory T cells (Treg)...
6.
Grimm J, Vargo J, Mavroidis P, Moiseenko V, Emami B, Jain S, et al.
Int J Radiat Oncol Biol Phys
. 2021 Feb;
110(1):147-159.
PMID: 33583641
Purpose: Dose-volume data for injury to carotid artery and other major vessels in stereotactic body radiation therapy (SBRT)/SABR head and neck reirradiation were reviewed, modeled, and summarized. Methods And Materials:...
7.
Redmond K, Gui C, Benedict S, Milano M, Grimm J, Vargo J, et al.
Int J Radiat Oncol Biol Phys
. 2021 Jan;
110(1):53-67.
PMID: 33390244
Purpose: As part of the American Association of Physicists in Medicine Working Group on Stereotactic Body Radiotherapy, tumor control probability (TCP) after stereotactic radiosurgery (SRS) and fractionated stereotactic radiosurgery (fSRS)...
8.
Mahadevan A, Moningi S, Grimm J, Li X, Forster K, Palta M, et al.
Int J Radiat Oncol Biol Phys
. 2020 Dec;
110(1):206-216.
PMID: 33358561
Purpose: Stereotactic body radiation therapy (SBRT) and stereotactic ablative body radiation therapy is being increasingly used for pancreatic cancer (PCa), particularly in patients with locally advanced and borderline resectable disease....
9.
Patel A, Rodriguez-Lopez J, Bahary N, Zureikat A, Burton S, Heron D, et al.
Adv Radiat Oncol
. 2020 Dec;
5(6):1197-1205.
PMID: 33305081
Purpose: There is no consensus on treatment volumes for adjuvant stereotactic body radiation therapy (SBRT) for pancreatic cancer. Herein, we report patterns of failure after pancreatic SBRT for close/positive margins,...
10.
Ling D, Vargo J, Grimm R, Gebhardt B, Clump D, Ferris R, et al.
J Radiosurg SBRT
. 2020 Dec;
7(2):89-94.
PMID: 33282462
We sought to evaluate the association between larynx dose and risk of severe late laryngeal toxicity in patients undergoing re-irradiation SBRT for recurrent HNC. Fifty-five patients with an intact larynx...